Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H2 | P55055 | 2/20 | 0.36 |
| ▸ | NR1H3 | Q13133 | 2/20 | 0.36 |
| ▸ | NTRK1 | P04629 | 8/20 | 0.35 |
| ▸ | GPR119 | Q8TDV5 | 4/20 | 0.34 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.34 |
| ▸ | GHSR | Q92847 | 1/20 | 0.33 |
| ▸ | UCHL1 | P09936 | 1/20 | 0.33 |
| ▸ | CNR1 | P21554 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL38652192 | 1.00 | NR1H2 (0.36) | NR1H2NR1H3NTRK1GPR119USP30 | |
| SCHEMBL38652321 | 1.00 | NR1H2 (0.36) | NR1H2NR1H3NTRK1GPR119USP30 | |
| SCHEMBL38652323 | 0.88 | NTRK1 (0.37) | NR1H2NR1H3NTRK1GPR119USP30 | |
| SCHEMBL38652404 | 0.85 | USP30 (0.42) | NR1H2NR1H3NTRK1GPR119USP30 | |
| SCHEMBL38652201 | 0.84 | RIPK1 (0.42) | NTRK1GHSR | |
| SCHEMBL38652263 | 0.83 | GRIN1 (0.38) | NTRK1GPR119 | |
| SCHEMBL38652022 | 0.78 | NTRK1 (0.37) | NR1H2NR1H3NTRK1USP30GHSR | |
| SCHEMBL38652258 | 0.78 | NR1H2 (0.35) | NR1H2NR1H3NTRK1USP30GHSR | |
| SCHEMBL26093240 | 0.76 | USP30 (0.42) | GPR119USP30 | |
| SCHEMBL38651986 | 0.74 | TRPV3 (0.47) | GPR119USP30 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122010910-A | Biazacycloalkane Menin-MLL protein inhibitor, pharmaceutical composition and application thereof | 赛诺哈勃药业（成都）有限公司 | 2026-05-12 | — | — | CN | disclosed |